DelMar Pharmaceuticals, Inc. (DMPI)
DelMar Pharmaceuticals is developing new cancer therapies in areas where patients are failing or have become intolerable to currently available treatments.
Click here to download the April 2011 Corporate Presentation (PDF, 540k)
